H1B Report
H-1B sponsorNJFEIN 47-2100951Updated Jul 2026

UNITED PHARMA TECHNOLOGIES, INC.

US H-1B Labor Condition Application activity for UNITED PHARMA TECHNOLOGIES, INC.. Filed 328 disclosures between FY2016 and FY2026 from worksites with a NJ headquarters indicator.

Total filings
11
Outside top-N · FY2026
Certified
90.9%
unconditional · FY2026
Withdrawn
0.0%
withdrawn rate · FY2026
Denied
0.0%
rejection rate · FY2026

H-1B outcome breakdown

Share of UNITED PHARMA TECHNOLOGIES, INC.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.

Outcome breakdown: Certified 90.6%, Cert-withdrawn 4.0%, Withdrawn 5.5%
Outcome breakdown
OutcomeShare
Certified90.6%
Cert-withdrawn4.0%
Withdrawn5.5%
Certified90.6%
Cert-withdrawn4.0%
Withdrawn5.5%

Top occupations sponsored

SOC codes filed most by UNITED PHARMA TECHNOLOGIES, INC. across all fiscal years. Click any row to open the national salary guide.

H-1B filings by fiscal year

Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.

YearFilings
FY201617
FY201743
FY201847
FY201946
FY20201
FY20215
FY20223
FY202326
FY202481
FY202548
FY202611
Time series: 11 points from FY2016 to FY2026
Time series
PeriodValue
FY201617
FY201743
FY201847
FY201946
FY20201
FY20215
FY20223
FY202326
FY202481
FY202548
FY202611
Compare UNITED PHARMA TECHNOLOGIES, INC. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Popular comparisons
Explore by rank
Pre-built leaderboards for the most-asked questions.